Table 2 MDT treatment recommendations for limb preservation
Variables | Patients n = 51 |
|---|---|
Vascular surgery intervention | 11 (21.6%) |
Arteriovenous loop | 2 (3.9%) |
Percutaneous transluminal angioplasty | 1 (2%) |
Angiography | 4 (7.8%) |
Vessel-extension by vein graft | 2 (3.9%) |
Plastic surgery intervention | 29 (56.9%) |
Free flaps | 26 (51.0%) |
Chimeric parascapular and latissimus flap | 8 (15.7%) |
Free groin flap | 1 (2.0%) |
Free iliac crest flap | 1 (2.0%) |
Latissimus dorsi flap | 7 (13.7%) |
Anterior lateral thigh flap | 4 (7.8%) |
Parascapular flap | 2 (3.9%) |
Rectus abdominis flap | 1 (2.0%) |
Free fibular flap | 2 (3.9%) |
Pedicled flap | 3 (5.9%) |
Trauma surgery intervention | 20 (39.2%) |
Osteosynthesis | 10 (19.6%) |
Antibiotic spacer removal | 1 (2.0%) |
Antibiotic spacer implantation | 3 (5.9%) |
Bone debridement | 7 (13.7%) |
Arthrodesis | 4 (13.7%) |
Endoprosthesis | 1 (2.0%) |
Resection arthroplasty | 3 (5.9%) |
Bioactive glass scaffold implantation | 1 (2.0%) |
Autogenous Bone grafting | 3 (5.9%) |
Allogeneic Bone grafting | 1 (2%) |
Implant removal | 7 (13.7%) |
Other intervention | 5 (9.8%) |
Intraoperative demonstration | 1 (2%) |
Home vacuum therapy | 4 (7.8%) |